Alector (ALEC) Profit After Tax (2018 - 2026)
Alector's (ALEC) quarterly Profit After Tax came in at -$23.0 million in Q2 2026, up 24.84% year-over-year from -$18.4 million in Q2 2025, and little changed quarter-over-quarter from -$22.9 million in Q1 2026.
Analysis
Alector (ALEC) Profit After Tax (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Profit After Tax for 9 consecutive years, with -$23.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Profit After Tax rose 24.84% year-over-year to -$23.0 million in Q2 2026; TTM through Jun 2026 was -$117.9 million, a 2.19% decrease from a year earlier, with the FY2025 full-year figure at -$143.0 million, down 20.14% from the prior year.
- Profit After Tax was -$23.0 million for Q2 2026 at Alector, roughly flat from -$22.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $9.9 million in Q2 2022 and troughed at -$50.3 million in Q4 2022.
- A 5-year average of -$31.7 million and a median of -$38.0 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 117.92% in 2022 and plunged 2912.8% in 2024, its largest moves.
- Over 5 years, Profit After Tax stood at -$50.3 million in 2022, then increased by 17.56% to -$41.4 million in 2023, then soared by 94.99% to -$2.1 million in 2024, then tumbled by 1698.36% to -$37.3 million in 2025, then jumped by 38.3% to -$23.0 million in 2026.
- The last three Profit After Tax figures came in at -$23.0 million (Q2 2026), -$22.9 million (Q1 2026), and -$37.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 472.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -23.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.01 Mn |
| Mar 31, 2026 | -22.93 Mn |
| Dec 31, 2025 | -37.30 Mn |
| Sep 30, 2025 | -34.67 Mn |
| Jun 30, 2025 | -30.62 Mn |
| Mar 31, 2025 | -40.47 Mn |
| Dec 31, 2024 | -2.07 Mn |
| Sep 30, 2024 | -42.22 Mn |
| Jun 30, 2024 | -38.68 Mn |
| Mar 31, 2024 | -36.08 Mn |
| Dec 31, 2023 | -41.43 Mn |
| Sep 30, 2023 | -44.48 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | -45.86 Mn |
| Dec 31, 2022 | -50.26 Mn |
| Sep 30, 2022 | -46.67 Mn |
| Jun 30, 2022 | 9.88 Mn |
| Mar 31, 2022 | -44.62 Mn |
| Dec 31, 2021 | -57.17 Mn |
| Sep 30, 2021 | 126.60 Mn |